Related Experiment Video
Updated: Jun 16, 2026
08:44
Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation
Published on: May 30, 2020
Regulation of allergy with RNA interference.
Motohiko Suzuki1, Xiufen Zheng, Xusheng Zhang
1Departments of Surgery and Pathology, University of Western Ontario, London, Ontario, Canada. suzu-mo@med.nagoya-cu.ac.jp
Critical Reviews in Immunology
|February 4, 2010
Summary
Small interfering RNA (siRNA) offers a novel therapeutic approach for allergic diseases by targeting their root causes. This RNA interference (RNAi) strategy inhibits key molecular targets, potentially controlling both allergy symptoms and underlying mechanisms.
Area of Science:
- Immunology
- Molecular Biology
- Pharmacology
Background:
- Allergic diseases like asthma and atopic dermatitis present significant clinical challenges.
- Current treatments manage symptoms but do not address the fundamental causes of allergic responses.
- Novel therapies targeting upstream causative events in allergic diseases are needed.
Purpose of the Study:
- To explore the potential of small interfering RNA (siRNA) in treating allergic diseases.
- To investigate RNA interference (RNAi) as a strategy for modulating molecular targets involved in allergic cascades.
- To highlight the inhibition of CD40 by siRNA as a method for controlling allergic reactions.
Main Methods:
- Utilizing RNA interference (RNAi) through small interfering RNA (siRNA) for targeted gene knockdown.
- Investigating molecular and cellular interactions within the allergic cascade.
- Demonstrating the inhibition of CD40 using siRNA to mitigate allergic responses.
Main Results:
- Small interfering RNA (siRNA) demonstrates potent and specific knockdown of molecular targets.
- The inhibition of CD40 by siRNA effectively reduces allergic reactions.
- RNAi-based therapies show promise in addressing the causative events of allergic diseases.
Conclusions:
- RNA interference (RNAi) via siRNA represents a promising therapeutic strategy for allergic diseases.
- siRNA therapies can potentially control both the symptoms and the underlying causes of allergic responses.
- Further research into siRNA applications for allergic diseases is warranted given demonstrated feasibility and safety.
Related Concept Videos
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
01:23Regulation of Expression at Multiple Steps
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...
01:29Translational Regulation
Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...